SLC5A2 and hydrops fetalis: The importance of SGLT2 inhibitors was further reinforced by a meta-analysis of the most major trials on gliflozins and HF (DELIVER, EMPEROR-Preserved, EMPEROR-Reduced, DAPA-HF, and SOLIST-WHF), regardless of EF, supporting their function as a cornerstone in HF therapy [65].